Literature DB >> 2847761

Interleukin-1 stimulation of phospholipase activity in rat synovial fibroblasts. Possible regulation by cyclooxygenase products.

R W Godfrey1, W J Johnson, S T Hoffstein.   

Abstract

Tritiated arachidonic acid (3H-AA)-labeled rat synovial fibroblasts stimulated with human recombinant interleukin-1 beta (rIL-1 beta) released incorporated radiolabel in a time-dependent and dose-dependent manner, with labeled prostaglandins representing 29% of the released radiolabel. Treatment of the cells with dibutyryl cAMP or prostaglandin E2 enhanced both spontaneous and rIL-1 beta-induced 3H-AA release; treatment with indomethacin or naproxen inhibited the response. The effects of these cyclooxygenase inhibitors on 3H-AA release were not reversed by the addition of prostaglandin E2. The activities of phospholipase A, phospholipase C, and diglyceride lipase were detected in the homogenates of rat synovial fibroblasts. Pretreatment of synovial cells with rIL-1 beta resulted in a threefold stimulation of phospholipase A activity and a slight increase in phospholipase C activity in cell homogenates. These data show that rIL-1 beta stimulates phospholipase activities in rat synovial fibroblasts and that at least one of these activities may be regulated by either prostaglandins or cAMP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847761     DOI: 10.1002/art.1780311112

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

1.  Effects of recombinant human IL-1 beta on production of prostaglandin E2, leukotriene B4, NAG, and superoxide by human synovial cells and chondrocytes.

Authors:  T Tawara; M Shingu; M Nobunaga; T Naono
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

2.  In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis.

Authors:  H Sano; T Hla; J A Maier; L J Crofford; J P Case; T Maciag; R L Wilder
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 3.  Cytokines and eicosanoids in rheumatic diseases.

Authors:  S J Hopkins
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

4.  Mechanisms of prostanoid synthesis in human synovial cells: cytokine-peptide synergism.

Authors:  J M Bathon; F H Chilton; W C Hubbard; M C Towns; N J Solan; D Proud
Journal:  Inflammation       Date:  1996-10       Impact factor: 4.092

5.  Effects of interferon gamma on cultured synovial cells from patients with rheumatoid arthritis: inhibition of cell growth, prostaglandin E2, and collagenase release.

Authors:  H Nakajima; Y Hiyama; W Tsukada; H Warabi; S Uchida; S Hirose
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

6.  Circulating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis.

Authors:  J A Green; G M Smith; R Buchta; R Lee; K Y Ho; I A Rajkovic; K F Scott
Journal:  Inflammation       Date:  1991-10       Impact factor: 4.092

7.  Compartmental heterogeneity of soluble phospholipases A.

Authors:  P Vadas; W Pruzanski; E Stefanski; B Sternby
Journal:  Inflammation       Date:  1990-04       Impact factor: 4.092

8.  Human keratinocyte sensitivity towards inflammatory cytokines varies with culture time.

Authors:  G Elliott; D Meent; J Dijk; M Mol
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.